Synthesis of doxorubicin–peptide conjugate with multidrug resistant tumor cell killing activity

Synthesis of doxorubicin–peptide conjugate with multidrug resistant tumor cell killing activity Overcoming drug resistance by cell-penetrating peptide-mediated delivery of a doxorubicin dimer with high DNA-binding affinity Novel Peptide–Doxorubucin Conjugates for Targeting Breast Cancer Cells Including the Multidrug Resistant Cells Synthesis and biological activity of conjugates between paclitaxel and the cell delivery vector penetratin Synthesis and antiproliferative activities of doxorubicin thiol conjugates and doxorubicin-SS-cyclic peptide Synthesis and preliminary antitumor activity evaluation of a DHA and doxorubicin conjugate Novel Cell-Penetrating Peptide Conjugated Proteasome Inhibitors: Anticancer and Antifungal Investigations Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells Design and application of hybrid cyclic-linear peptide-doxorubicin conjugates as a strategy to overcome doxorubicin resistance and toxicity Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment